Product correctly added to cart.

discount label
Pomalidomide-PEG6-COOH
View 3D

Biosynth logo

Pomalidomide-PEG6-COOH

CAS: 2225148-49-0

Ref. 3D-APD14849

100mgTo inquire
250mgTo inquire
Estimated delivery in United States, on Monday 26 Aug 2024

Product Information

Name:
Pomalidomide-PEG6-COOH
Description:

Pomalidomide-PEG6-COOH is a compound that belongs to the family of acid PEGs. It is created through pegylation, a process that involves attaching a PEG linker to a molecule. In this case, the PEG linker is attached to pomalidomide, resulting in Pomalidomide-PEG6-COOH. This compound is classified as a heterobifunctional PEG, meaning it has two different functional groups - an amido group and a carboxylic acid group.

The addition of the PEG linker provides several benefits to Pomalidomide-PEG6-COOH. Firstly, it increases the solubility and stability of the compound, making it easier to handle and administer. Additionally, pegylation can enhance the pharmacokinetics and therapeutic efficacy of drugs by increasing their circulation time in the body.

Pomalidomide-PEG6-COOH is part of a range of PEG products

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Biosynth
Long term storage:
Notes:

Chemical properties

Molecular weight:
609.6 g/mol
Formula:
C28H39N3O12
Purity:
Min. 95%
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: 3D-APD14849 Pomalidomide-PEG6-COOH

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".